The purpose of this article is to determine the effect of mediing equations were used to assess change in PURPOSE, USE,cation reviews on patient understanding of and compliance COMPLIANCE, INTERACTION, and REACTION over time. to medications for participants in the Cenla Medication Ac All effects were adjusted for differences in age, race, gender, cess Program (CMAP). A sample of 844 individuals with a to the number of years of education, total number of medicatal of 2013 reviews over a period of 6 months to 1 year protions per patient, and the patient’s primary diagnosis. Signifiduced 5 outcome variables: the percentage of the total cant increases were observed for PURPOSE, USE, and number of drugs the patient understands the purpose of COMPLIANCE. A significant decrease was observed for (PURPOSE), understands the proper use of (USE), and is INTERACTION. No significant difference in REACTION was compliant with (COMPLIANCE) and the percentage of paobserved over time. CMAP has seen increases in patient untients that experienced any drug-drug or drug-disease interderstanding and compliance, as well as a decrease in drug-actions (INTERACTION) or any adverse reactions drug and drug-disease interactions through the first year of (REACTION). Mixed-effects models and generalized estimat medication reviews.
Lassila HC, Stoehr GP, Ganguli M, et al. Use of prescription medications in an elderly rural population: the MoVIES Project. Ann Pharmacother. 1996;30:589-595.
2.
Schrader SL, Dressing B, Blue R, Jensen G, Miller D, Zawada ET. The Medication Reduction Project: combating polypharmacy in South Dakota elders through community-based interventions. SD J Med. 1996;49:441-448.
3.
McDonald HP, Garg AX, Haynes RB. Interventions to enhance patient adherence to medication prescriptions. JAMA. 2002;288:2868-2879.
4.
Cohen JS. Preventing adverse drug reactions before they occur. Medscape Pharmacotherapy[serial online]. 1999;1(2).
5.
Col N, Fanale JE, Kronholm P.The role of medication noncompliance and adverse drug reactions in hospitalizations of the elderly. Arch Intern Med. 1990;150:841-845.
6.
Hayes JD, Sansgiry SS, Rice GK. Patient satisfaction with a pharmacist-based medication assistance clinic. Am J Health Syst Pharm. 2002;59:2456-2456.
7.
Oh Y, McCombs JS, Cheng RA, Johnson KA. Pharmacist time requirements for counseling in an outpatient pharmacy. Am J Health Syst Pharm. 2002;59:2346-2355.
8.
Hanlon JT, Weinberger M, Samsa GP, Schmader KE, Uttech KM, Lewis IK. A randomized, controlled trial of a clinical pharmacist intervention to improve inappropriate prescribing in elderly outpatients with polypharmacy. Am J Med. 1996;100:428-437.
9.
Sturgess IK, McElnay JC, Hughes CM, Crealey G.Community pharmacy based provision of pharmaceutical care to older patients. Pharm World Sci. 2003;25:218-226.
10.
Taylor CT, Byrd DC, Krueger K.Improving primary care in rural Alabama with a pharmacy initiative. Am J Health Syst Pharm. 2003;60:1123-1129.
11.
Peterson AM, Takiya L, Finley R.Meta-analysis of trials of interventions to improve medication adherence. Am J Health Syst Pharm. 2003;60:657-665.
12.
Borgsdorf LR, Miano JS, Knapp KK. Pharmacist-managed medication review in a managed care system. Am J Hosp Pharm. 1994;51:772-777.
13.
Ali F, Laurin MY, Lariviere C,Tremblay D, Cloutier D. Theeffect of pharmacist intervention and patient education on lipid-lowering medication compliance and plasma cholesterol levels. Can J Clin Pharmacol. 2003;10:101-106.
14.
Berringer R, Shibley MCH, Cary CC, Pugh CB, Powers PA, Rafi JA. Outcomes of a community pharmacy-based diabetes monitoring program. J Am Pharm Assoc. 1999;39:791-797.
15.
Morrison A, Wertheimer AI. Evaluation of studies investigating the effectiveness of pharmacists’ clinical services. Am J Health Syst Pharm. 2001;58:569-577.
16.
Norris SL, Lau J, Smith SJ, Schmid CH, Engelgau MM. Self-management education for adults with type 2 diabetes. Diabetes Care. 2002;25:1159-1171.
17.
Cranor CW, Bunting BA, Christensen DB. The Asheville Project: long-term clinical and economic outcomes of a community pharmacy diabetes care program. J Am Pharm Assoc. 2003;43:173-184.
18.
Cranor CW, Bunting BA, Christensen DB. The Asheville Project: short-term outcomes of a community pharmacy diabetes care program. J Am Pharm Assoc. 2003;43:149-159.
19.
Carter BL, Barnette DJ, Elizabeth C, Mazzotti GJ, Asali ZJ. Evaluation of hypertensive patients after care provided by community pharmacists in a rural setting. Pharmacotherapy. 1997;17:1274-1285.
20.
Riesen WF, Darioli R, Noll G.Lipid-lowering therapy: strategies for improving compliance. Curr Med Res Opin. 2004;20:165-173.
21.
Lipton HL, Bird JA. The impact of clinical pharmacists’ consultations of geriatric patients’ compliance and medical care use: a randomized controlled trial. Gerontologist. 1994;34:307-315.
22.
Munroe WP, Kunz K, Dalmady-Israel C, Potter L, Schonfeld WH. Economic evaluation of pharmacist involvement in disease management in a community pharmacy setting. Clin Ther. 1997;19:113-123.
23.
Chabot I, Moisan J, Gregoire JP, Milot A.Pharmacist intervention program for control of hypertension. Ann Pharmacother. 2003;37:1186-1193.
24.
Fulmer TT, Feldman PH, Kim TS, et al. An intervention study to enhance medication compliance in community-dwelling elderly individuals. J Gerontol Nurs. 1999;25:6-14.
25.
Johnson KA, Parker JP, McCombs JS. The Kaiser Permanente/USC patient consultation study: patient satisfaction with pharmaceutical services. Am J Health Syst Pharm. 1998;55:2621-2629.
26.
McCombs JS, Gordon L, Shi J, et al. The Kaiser Permanente/USC patient consultation study: change in use and cost of health care services. Am J Health Syst Pharm. 1998;55:2485-2499.
27.
Schectman JM, Nadkarni MM, Voss JD. The association between diabetes metabolic control and drug adherence in an indigent population. Diabetes Care. 2002;25:1015-1021.
28.
Harmon GN, Lefante J, Roy W, et al. Outpatient medication assistance program in a rural setting. Am J Health Syst Pharm. 2004;61:603-607.
29.
Singer J, Willett J.Applied Longitudinal Data Analysis. New York, NY: Oxford University Press; 2003.
Resnik DB, Ranelli PL, Resnik SP. The conflict between ethics and business in community pharmacy: what about patient counseling?J Bus Ethics. 2000;28:179-186.
33.
Campbell RK. Role of the pharmacist in diabetes management. Am J Health Syst Pharm. 2002;59:S18-S21.
